Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CYIO Great catching up with Ralph Amato, CEO of Noir Medical Supplies, our recent acquisition! 🚚📦 Warehouse packed & stacked with medical supply products ready for shipping. Warehouse inventory generally turns every 4-7 days —things are moving fast! #NoirMedical #growth pic.twitter.com/OuDuwUzQiY
— CYIOS Corporation (@cyioscorp) September 20, 2024
🚨 $CYIO Updates Coming Soon! Looking forward to present at the next Emerging Growth Conference on Sept. 26 @ 4:25pm ET! Joining Chairman John O’Shea will be Ralph Amato, CEO Noir Medical Supplies, recently acquired by #CYIOS. Expect upwardly revised rev. guidance and a strong…
— CYIOS Corporation (@cyioscorp) September 19, 2024
Chart says bottom formed now we turn.
This should be trading in the $0.02-$0.03 range according to value.
CYIOS Corporation $CYIO has been on fire lately! The recent product launch exceeded expectations and the market response has been overwhelmingly positive. Definitely a company to watch!
Just read the latest report on CYIOS Corporation $CYIO and the numbers are looking fantastic. Their strategic partnerships are clearly paying off. Great time to be holding this stock!
CYIOS Corporation ($CYIO) is really showing some impressive growth. Their latest innovation is making waves in the industry. Excited to see where this leads in the coming quarters!
Projected growth to $10M revenue in 2025 for Noir Medical Supplies!
$CYIO Live interview link: https://x.com/i/spaces/1lPJqODaLgbKb
Things are really starting to heat up here
This acquisition brings a lot of value to CYIO. Over $4.5M in revenue in 2024 and projecting $7M this year. Cash flow positive as well!
Looking forward to the spaces today too: https://x.com/i/spaces/1lPJqODaLgbKb
$CYIO Announces it has Closed the Acquisition of Noir Medical Supplies.
— CYIOS Corporation (@cyioscorp) September 11, 2024
Noir Expects to see Strong Revenue Growth in 2024 Exceeding $7 Million, up from $4.6 Million in 2023. https://t.co/kyXiTuahyu
Join us live today at 4:05PM EST for additional information.… pic.twitter.com/UOUC61ox1e
$CYIO Announces it has Closed the Acquisition of Noir Medical Supplies.
Noir Expects to see Strong Revenue Growth in 2024 Exceeding $7 Million, up from $4.6 Million in 2023.
https://twitter.com/i/spaces/1lPJqODaLgbKb
Exciting stuff for $CYIO tomorrow. Mr Robot is doing an interview
Medical supply company is juicy.
$CYIO Emerging Growth Conference Highlights
- Executed bonding contract to acquire privately held medical supply company.
- Generated revenue in excess of $4.5 Million last year.
- Experienced management group that has agreed to stay on board.
- 2 well established warehouses in Florida.
- Strong growth pipeline, analyzing additional business models.
- Company accounts being audited.
- Strong revenue forecasts for 2025.
- Acquisition provides long term shareholder value and positive cash flow.
$CYIO spot on analysis in this post!
CYIO Initial valuation and price per share assumptions
Obviously, investors should do their own due diligence and come up with their own valuation model. That being said, I’ve gone ahead and come up with some general targets, based on the currently available public info. I believe we can extrapolate some basic valuation metrics to come up with a projected share price now that this acquisition is officially closed.
Assuming 272 million shares outstanding, here's a breakdown of what the the market cap of the company would be based on reaching various share prices:
• $0.02 per share: Market Cap = $5.4 million (Just over 1x LAST YEAR - 2023 revenues)
• $0.03 per share: Market Cap = $8.1 million
• $0.05 per share: Market Cap = $13.6 million
• $0.06 per share: Market Cap = $16.3 million
• $0.075 per share: Market Cap = $20.4 million
• $0.10 per share: Market Cap = $27 million
What we know so far from the publicly disclosed info is that 2024 & 2025 should have “significant year over year revenue growth”. Let’s just say conservatively it’s approx 50% YOY rev growth. That’s a BIG number!!....which puts us around $6.5-7m in revs for 2024.
Putting a reasonable multiplier of say 2x or 3x on the current year 2024 revs, should give us an idea of where the pps should be perhaps right now, TODAY…not next year, quite literally, Today!!
Using that rev. assumption and market multiplier, you get a mkt cap value in a range of lets say between $15-21million.
Using the valuation table above, would indicate a fair and reasonable current share price TODAY of around say .07c.
Looking to next yr, let’s say they do $10m or $12m in revs based on prior two yr track record of showing consistent 50% YOY revenue growth…for illustration purposes only, lets use the middle number of $11m in 2025 revs and a 3x multiplier: $11m x 3x = $33m mkt cap…putting this well above .10c
CYIO just posted huge updates coming. This is exciting!!
Looking forward to a solid week
Set a reminder for my upcoming live interview with @cyioscorp to discuss their multi-million dollar revenue acquisition and more! $CYIO
— Super Robot 🤖🦒 (@SuperRobotOTC) September 5, 2024
This Wednesday at 4:05 PM EST!
https://t.co/4SmKyygtzB
Here you go. It’s this Wed., 9/11/24. Thanks.
Set a reminder for my upcoming live interview with @cyioscorp to discuss their multi-million dollar revenue acquisition and more! $CYIO
— Super Robot 🤖🦒 (@SuperRobotOTC) September 5, 2024
This Wednesday at 4:05 PM EST!
https://t.co/4SmKyygtzB
A friend told me the CEO was interviewing this week. Does anyone have the link for the interview on CYIO? Thank you kindly.
Definitely poised to go higher. The merger immediately means revenues. They are growing, a game changer. Thanks.
Came over from the X. A lot of buzz on this one. CYIO looks to explode in the coming weeks. Great stuff here guys!
Very nice. I agree with the sentiment this is a very promising move. I cannot wait for the future.
Will be watching this come Monday morning.
Great break down! Thank you!
Initial valuation and price per share assumptions
Obviously, investors should do their own due diligence and come up with their own valuation model. That being said, I’ve gone ahead and come up with some general targets, based on the currently available public info. I believe we can extrapolate some basic valuation metrics to come up with a projected share price now that this acquisition is officially closed.
Assuming 272 million shares outstanding, here's a breakdown of what the the market cap of the company would be based on reaching various share prices:
• $0.02 per share: Market Cap = $5.4 million (Just over 1x LAST YEAR - 2023 revenues)
• $0.03 per share: Market Cap = $8.1 million
• $0.05 per share: Market Cap = $13.6 million
• $0.06 per share: Market Cap = $16.3 million
• $0.075 per share: Market Cap = $20.4 million
• $0.10 per share: Market Cap = $27 million
What we know so far from the publicly disclosed info is that 2024 & 2025 should have “significant year over year revenue growth”. Let’s just say conservatively it’s approx 50% YOY rev growth. That’s a BIG number!!....which puts us around $6.5-7m in revs for 2024.
Putting a reasonable multiplier of say 2x or 3x on the current year 2024 revs, should give us an idea of where the pps should be perhaps right now, TODAY…not next year, quite literally, Today!!
Using that rev. assumption and market multiplier, you get a mkt cap value in a range of lets say between $15-21million.
Using the valuation table above, would indicate a fair and reasonable current share price TODAY of around say .07c.
Looking to next yr, let’s say they do $10m or $12m in revs based on prior two yr track record of showing consistent 50% YOY revenue growth…for illustration purposes only, lets use the middle number of $11m in 2025 revs and a 3x multiplier: $11m x 3x = $33m mkt cap…putting this well above .10c
Now, let’s discuss variables and unknown factors that could cause significantly higher targets;
1. How does having a tight cap structure and perhaps having a locked float situation, affect these numbers….i’d argue, that variable could maybe double the above numbers on potential pps
2. The biggest variable is potential other acquisitions….so, maybe you can double the valuation again?? Time will tell.
In summary, based on these metrics and assumptions, the stock appears undervalued below $0.10 and particularly attractive below $0.075.
Please note, these are personal opinions and not financial advice. Always conduct your own research before making investment decisions.
$CYIO
$CYIO Strong push off the 20 day MA.. makes me think this could test recent highs… pic.twitter.com/HlV1gD07BY
— Chris from Massachusetts AKA TommyboyTrader (@autumnsdad1) September 7, 2024
Yeah I think we’re all going to be rich
$4.5M Revenue company acquisition just confirmed !
PR coming out next Tuesday !
Get ready for this one to blow.
Agree! Great start and again, just getting underway here and at a really low PPS. Looking better! Thanks.
After seeing many deals fall through in the OTC space, officially closing this one is a big deal.
Just happened to catch a Cyio banner. Looks great!!! Words getting around
$CYIO pt. .05 on the conservative side. Holy smokes let’s go!
Wow! Severely undervalued.
I can’t begin to describe how great this looks. Breaking out, with massive news acquiring a medical device company that did 4.5m in revenue in 2023 with positive cash flow and higher forecasts for 2024 and 2025.
Big interview on twitter on Wednesday with PR coming sometime next week. This thing is big. The revenue is higher than the market cap. Anything under .03 is a gift. I have over 8m shares and will look to add more in the coming days.
Have a great weekend🚀
Followers
|
216
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
14960
|
Created
|
01/18/07
|
Type
|
Free
|
Moderators HulkInvestment |
Meet CarbonCred, our innovative carbon offsetting platform that empowers businesses, families, and consumers to drastically reduce their carbon footprint quickly and easily by purchasing carbon offsets that support a variety of verified carbon offsetting projects via monthly subscription plans.
Meet Helio, a CeFi aggregator. Helio finds out your exact crypto loan requirements, across various currencies, interest rates and loan terms, and shops around multiple lenders to find the best fit. Helio does not hold crypto nor provide direct lending from our own account. However, Helio strictly acts as a referral partner to our lending panel and receives a fee for referring parties to direct lenders.
Meet Randombly, a platform offering users the ability to mint a wide range of digital art and collectibles into NFT’s, including images, audio, 3D art, videos, crates, bundles and more. Utilizing Ethereum and the ERC-721 Non-Fungible and ERC1155 Multi-Fungible Token Standard smart contracts, enabling artists, investors, collectors, and publishers to mint, auction, and house their digital art, all in one place.
Meet Immortals Group, a consultancy who works with IP owners to design, produce, market, and sell unique collections of NFTs including the development of NFT roadmaps & white papers, with NFT utility as well as building of the community designed to establish the brand/IP with a robust secondary market.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |